Related Experiment Video
Updated: Jul 16, 2026

Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer
Published on: February 13, 2019
Keshan disease and mitochondrial cardiomyopathy
1National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China. Yangfy@sun5.ibp.ac.cn
Insights
Keshan disease, a heart condition, is linked to mitochondrial damage and selenium deficiency. Research suggests classifying it as a type of mitochondrial cardiomyopathy, improving understanding of its causes and treatment.
Area of Science:
- Cardiology
- Biochemistry
- Pathology
Background:
- Keshan disease (KD) is a fatal cardiomyopathy endemic to specific regions of China.
- Previous research on mitochondrial cardiomyopathy was limited before the Chuxiong investigation.
Purpose of the Study:
- To investigate the pathogenic mechanisms of Keshan disease.
- To evaluate the classification of Keshan disease as a mitochondrial cardiomyopathy.
Main Methods:
- A multidisciplinary investigation involving epidemiologists, clinicians, pathologists, biochemists, biophysicists, and environmental specialists.
- Pathological, biochemical, and biophysical analyses of myocardial tissue from KD patients and controls.
- Assessment of mitochondrial function, including oxidative phosphorylation and key molecular components.
Main Results:
- Myocardium in KD patients showed enlarged mitochondria with distended cristae.
- Significant reductions in oxidative phosphorylation enzyme activity, CoQ, cardiolipin, selenium, and GSHPx activity were observed.
- Increased calcium ion (Ca2+) content and decreased selenium levels were noted in affected mitochondria.
Conclusions:
- Mitochondria are identified as the primary target of pathogenic factors in Keshan disease.
- Keshan disease is proposed to be classified as a form of mitochondrial cardiomyopathy.
- Understanding KD's mechanism provides insights into general mitochondrial cardiomyopathy research.
Abstract:
Keshan disease (KD) is a potentially fatal form of cardiomyopathy (disease of the heart muscle) endemic in certain areas of China. From 1984 to 1986, a national comprehensive scientific investigation on KD in Chuxiong region of Yunnan Province in the southwest China was conducted. The investigation team was composed of epidemiologists, clinic doctors, pathologists, biochemists, biophysicists and specialists in ecological environment. Results of pathological, biochemical and biophysical as well as clinical studies showed: an obvious increase of enlarged and swollen mitochondria with distended crista membranes in myocardium from patients with KD; significant reductions in the activity of oxidative phosphorylation (succinate dehydrogenase, cytochrome oxidase, succinate oxidase, H(+)-ATPase) of affected mitochondria; decrease in CoQ, cardiolipin, Se and GSHPx activity, while obvious increase in the Ca2+ content. So, it was suggested that mitochondria are the predominant target of the pathogenic factors of KD. Before Chuxiong KD survey only a few cases of mitochondrial cardiomyopathy were studied. During the multidisciplinary scientific investigation on KD in Chuxiong a large amount of samples from KD cases and the positive controls were examined. On the basis of the results obtained it was suggested that KD might be classified as a "Mitochondrial Cardiomyopathy" endemic in China. This is one of the achievements in the three years' survey in Chuxiong and is valuable not only to the deeper understanding of pathogenic mechanism of KD but also to the study of mitochondrial cardiomyopathy in general. Keshan disease is not a genetic disease, but is closely related to the malnutrition (especially microelement Se deficiency). KD occurs along a low Se belt, and Se supplementation has been effective in prevention of such disease. The incidence of KD has sharply decreased along with the steady raise of living standard and realization of preventive measures. At present, patients of KD are very sparse. In recent years the research on the non-KD mitochondrial cardiomyopathy has progressed rapidly. Given the advances in this aspect a minireview is written to evaluate the classification of KD as a kind of mitochondrial cardiomyopathy.
More Related Videos
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
08:56Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitral Stenosis I: Introduction